Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Carefirst Caremark / Augtyro

Augtyro — Carefirst Caremark

3 indications indexed for this drug.

Recurrent Advanced Or Metastatic Ntrk Gene Fusion Positive N
View coverage criteria
Recurrent Advanced Or Metastatic Ros1 Positive Non Small Cel
View coverage criteria
Solid Tumors With Ntrk Gene Fusion
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.